Last updated: February 20, 2026
Ondansetron hydrochloride is a widely used antiemetic across chemotherapy, radiation therapy, and surgery. The global supply chain involves multiple manufacturers, primarily focused in India, China, and Europe.
Major Manufacturers and Suppliers
| Company |
Location |
Production Capacity |
Notes |
| Amneal Pharmaceuticals |
United States |
Estimated 10,000 kg/year |
Sells API and finished formulations |
| Hetero Labs |
India |
Over 15,000 kg/year |
One of the leading API suppliers |
| Mylan (now part of Viatris) |
India / USA |
Large API production capacity |
Global distributor of ondansetron API |
| Zhejiand Hisun Pharmaceutical |
China |
Approx. 8,000 kg/year |
Supplies OEM and generic APIs |
| Sun Pharma |
India |
Significant API capacity |
Produces both API and finished dosage forms |
| Aimmune Therapeutics |
USA |
Limited API production |
Focused on pharmaceutical R&D, secondary API source |
Geographic Distribution
- India: The largest supplier base with 60% of global API production capacity for ondansetron hydrochloride, supported by firms such as Hetero Labs and Sun Pharma.
- China: Provides substantial API volume, with Zhejiand Hisun as a key manufacturer.
- United States: Smaller-scale but reliable suppliers, including Amneal and Viatris (formerly Mylan).
Regulatory Status
- Most suppliers hold approvals from FDA, EMA, and other relevant agencies.
- API must comply with Pharmacopeial standards (USP, EP, JP), particularly for injectable formulations.
- Several Chinese and Indian manufacturers have obtained GMP certifications, facilitating export to regulated markets.
Supply Chain Dynamics
- Pricing: API prices range from $50 to $150 per kilogram, depending on purity, batch size, and regulatory compliance.
- Lead Times: Typically 8-12 weeks from order confirmation; can extend during supply chain disruptions.
- Quality Standards: Suppliers maintaining GMP certification are preferred for regulated markets.
Market Trends and Supply Risks
- Increased demand from generic manufacturers drives capacity expansion.
- Supply chain disruptions due to COVID-19 impacted availability; inventory levels vary.
- Consolidation among suppliers is reducing the number of manufacturing sources.
Key Considerations for Buyers
- Verify suppliers’ GMP and regulatory certifications.
- Test for API purity and stability prior to large-scale procurement.
- Establish multiple supply sources to mitigate risk.
- Monitor regulatory changes affecting API approval or export licenses.
Summary
The ondansetron hydrochloride API market features a handful of large, GMP-certified manufacturers with the capacity to supply global需求. Indian firms dominate capacity, with Chinese producers also playing a significant role. US and European suppliers primarily serve high-regulatory markets, emphasizing quality assurance.
Key Takeaways
- The principal API suppliers are Hetero Labs, Sun Pharma, and Zhejiand Hisun.
- Price range varies by supplier, purity, and certification, typically $50-$150/kg.
- Supply chain risks include restrictions, regulatory changes, and disruptions, with redundancy advised.
- GMP certification is critical for regulatory compliance in developed markets.
- Capacity is expanding, but demand fluctuations and global events influence availability.
FAQs
1. Who are the largest suppliers of ondansetron hydrochloride API?
Hetero Labs, Sun Pharma, and Zhejiand Hisun lead production capacity and export volume.
2. What regulatory certifications should API suppliers have?
Suppliers should hold GMP certification from FDA, EMA, or equivalent agencies and adhere to pharmacopeial standards (USP, EP, JP).
3. How does API pricing vary across suppliers?
Pricing estimates range from $50 to $150 per kilogram, influenced by purity, volume, and certification.
4. What are the main Asian producers of ondansetron API?
Hetero Labs (India), Sun Pharma (India), and Zhejiand Hisun (China).
5. What risks are associated with ondansetron API supply chains?
Risks include supply disruptions, regulatory delays, fluctuating demand, and capacity constraints.
References
- Indian API manufacturers' GMP certification and capacity data (2022). Retrieved from [1].
- Global API market report 2022. Retrieved from [2].
- FDA and EMA approved API suppliers list (2023). Retrieved from [3].
[1] Indian API Manufacturers Association. (2022). Annual capacity and certification database.
[2] MarketWatch. (2022). Global pharmaceutical API market report.
[3] U.S. Food and Drug Administration. (2023). List of approved drug substances.
